Operates in pharmaceutical manufacturing and marketing. Develops formulations across therapeutic categories. Business model includes contract manufacturing and branded generics. Revenue is earned through product sales to distributors. Focuses on compliance-driven production. Serves domestic healthcare markets.
Loading chart…
This company hasn't held an earnings call in the last six months, so there's no recent commentary from management. Our deep dives are built on what management actually said, so we haven't prepared one.
20 fields couldn't be derived. The company was scraped before the cash-flow and balance-sheet rows were captured. Re-running an analysis will refresh these.